Myeloma Matters – Winter 2016
In this issue:
We interview a Professor at Imperial College London who explains his team’s role in taking a new drug, DTP3, from the laboratory into early phase clinical trials in patients.
Meindert Boysen, Programme Director at the National Institute for Health and Care Excellence talks about the new Cancers Drugs Fund and whether it will improve access to new treatments.
Dr Chris Parrish provides an insight into a type of immunotherapy called ‘adoptive T cell transfer’ which is currently being studied in myeloma.
Living well with myeloma
This feature looks at how to avoid infection; tips for managing constipation and diarrhoea; and coping with anxiety and depression.
Ed Jones talks about his diagnosis of myeloma, the treatment he has received and the effect the diagnosis has had on his life.